Shandong Weigao Blood Purification Products Co (SHSE:603014) ROCE %: 7.72% (As of Mar. 2026)


SHSE:603014 Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
38 GF Score
Price ¥35.98
! 2 Warning Signs
View Full Analysis

What is Shandong Weigao Blood Purification Products Co ROCE %?

Shandong Weigao Blood Purification Products Co SHSE:603014 +2.36% 38 ROCE % is 7.72% as of Mar. 2026. GuruFocus rates SHSE:603014 with a GF Score™ of 38/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shandong Weigao Blood Purification Products Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 7.72%.

Shandong Weigao Blood Purification Products Co  (SHSE:603014) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shandong Weigao Blood Purification Products Co ROCE % Related Terms

Shandong Weigao Blood Purification Products Co ROCE % Historical Data

* Premium members only.

The historical data trend for Shandong Weigao Blood Purification Products Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Weigao Blood Purification Products Co ROCE % Chart

Shandong Weigao Blood Purification Products Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial 11.03 9.84 9.18 8.84 8.96

Shandong Weigao Blood Purification Products Co Quarterly Data
Dec20 Dec21 Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.37 8.21 8.17 9.54 7.72
SHSE:603014
38GF Score
Shandong Weigao Blood Purification Products Co Ltd SHSE:603014
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shandong Weigao Blood Purification Products Co ROCE % Calculation

Shandong Weigao Blood Purification Products Co's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=576.565/( ( (6990.147 - 1311.757) + (8608.491 - 1415.381) )/ 2 )
=576.565/( (5678.39+7193.11)/ 2 )
=576.565/6435.75
=8.96 %

Shandong Weigao Blood Purification Products Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=560.996/( ( (8608.491 - 1415.381) + (8595.761 - 1259.143) )/ 2 )
=560.996/( ( 7193.11 + 7336.618 )/ 2 )
=560.996/7264.864
=7.72 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 7.72% mean?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a ROCE % of 7.72% as of Mar. 2026.
Is Shandong Weigao Blood Purification Products Co's ROCE % too high?
Shandong Weigao Blood Purification Products Co's current ROCE % is 7.72%. The Medical Devices & Instruments industry median ROCE % is 2.20. Shandong Weigao Blood Purification Products Co's value of 7.72% is 250.9% above this industry median. Overall, Shandong Weigao Blood Purification Products Co has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Shandong Weigao Blood Purification Products Co's ROCE % compare to ABT and SYK?
Shandong Weigao Blood Purification Products Co's ROCE % of 7.72% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.20. Shandong Weigao Blood Purification Products Co's value of 7.72% is 250.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.20, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Weigao Blood Purification Products Co's current ROCE % of 7.72% is 250.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Weigao Blood Purification Products Co's current ROCE % is 7.72%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Weigao Blood Purification Products Co stock overvalued right now?
Shandong Weigao Blood Purification Products Co (SHSE:603014) has a current ROCE % of 7.72%. The current ROCE % is 7.72% and 250.9% above the Medical Devices & Instruments industry median of 2.20. Shandong Weigao Blood Purification Products Co's overall GF Score™ is 38/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Shandong Weigao Blood Purification Products Co (SHSE:603014), the current ROCE % is 7.72% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shandong Weigao Blood Purification Products Co Business Description

Address No. 7, Weigao West Road, Torch High-tech Industrial Development Zone, Shandong Province, Weihai, CHN, 264200
Shandong Weigao Blood Purification Products Co Ltd engaged in research and development, production and sales of blood purification medical products.
38GF Score

Get the complete analysis for SHSE:603014

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥35.98
Price